Accéder au contenu
Merck
  • Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress.

Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress.

Oncology reports (2014-10-22)
Xia Jiang, Tatsuo Kanda, Shingo Nakamoto, Yuki Haga, Reina Sasaki, Masato Nakamura, Shuang Wu, Rintaro Mikata, Osamu Yokosuka
RÉSUMÉ

The present study examined the expression of glucose‑regulated protein 78 (GRP78/Bip) in human pancreatic cancer cell lines and the effect of knockdown of GRP78 on the cleavage of poly(ADP-ribose) polymerase (PARP). Human pancreatic cancer cell lines (KP-2, MIAPaCa-2, Panc-1 and SUIT-2), constitutively expressed GRP78. We also demonstrated that ER stress induced by thapsigargin upregulated protein levels of GRP78. In the presence of thapsigargin, knockdown of GRP78 enhanced the PARP cleavage in the human pancreatic cancer cells. These results provide evidence that GRP78 is a potential therapeutic target for 'difficult-to-treat' pancreatic cancer, in which ER stress signaling in part falls into disorder.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Thapsigargine, ≥98% (HPLC), solid film
Sigma-Aldrich
MISSION® esiRNA, targeting human HSPA5
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Hspa5